Positioning in the sexually transmitted disease (STD) treatment market and growing market share globally

0

The sexually transmitted disease (STD) treatment market is expected to have a very positive outlook for the next eight years 2021-2027. This research report emphasizes on key industry analysis, market size, share, growth, and extended industry dynamics with respect to drivers, opportunities, price details. and the latest industry trends.

The global Sexually Transmitted Disease (STD) Treatment market analysis further provides a pioneering market landscape along with a history of the market rise and key developments involved in the industry. The report also presents a comprehensive research study for professional survey of industries with high growth potential with market analysis. The Sexually Transmitted Disease (STD) Treatment Market report helps companies understand market trends and future market prospects, opportunities, and articulate critical business strategies.

Request a sample copy of the report here

Sexually transmitted diseases (STDs) also called sexually transmitted infections (STIs) or venereal diseases are infections acquired and transmitted from person to person during sexual activity through bodily fluids such as semen, vaginal fluids or the blood. Bacteria, parasites, yeasts and viruses are the causative agents of STDs. Additionally, symptoms seen in patients with STDs include rashes, warts, abdominal pain, or genital ulcers. A physical exam or tests such as ELISA (Enzyme Linked Immunosorbent Assay), a rapid plasma reagent blood test, or an antibody uptake blood test are commonly done to detect STDs.

The growth of the sexually transmitted disease treatment market is attributed to the increasing burden of disease, government initiatives to raise awareness, the growing diagnosis of sexually transmitted diseases, and the increase in the number of products in pipeline by key players in the treatment of STDs.

Sexually Transmitted Disease Treatment Market – Pilot

The increasing burden of sexually transmitted diseases is expected to propel the growth of the sexually transmitted disease treatment market during the forecast period. Among all STDs, the most common STDs include gonorrhea, chlamydia, syphilis, herpes, hepatitis (HBV), and human immunodeficiency virus (HIV). For example, according to the Centers for Disease Control and Prevention (CDC), in 2016, 1,598,354 cases of Chlamydia trachomatis infection were reported in the United States, corresponding to 497.3 cases per 100,000 in 2015. Additionally , 468,514 cases of gonorrhea were reported for a rate of 145.8 cases per 100,000 inhabitants, an increase of 18.5% compared to 2015. Unprotected sexual practice is one of the main factors of the increased incidence of STDs, which in turn stimulates demand for STD treatment. For example, according to the World Health Organization (WHO), unprotected sex is the second most common risk factor for increased disease burden.

The number of products under development for the treatment of HIV is high, which is expected to fuel the growth of the sexually transmitted disease treatment market during the forecast period. For example, in 2017, GSK and ViiV Healthcare filed an application with the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) for regulatory affiliation of a single tablet to two medicines based on dolutegravir (by ViiV Healthcare) and rilpivirine. (by Janssen) indicated for the treatment of HIV-1 infection. In addition, other drug candidates in development include – PrEP, PRO140 with ibalizumab, BMS-955176, which are expected to be launched during the forecast period. In addition, governments are focusing on funding research and development programs, which is expected to drive the growth of the market. For example, the British Columbia Center for Disease Control sponsored studies of the drug doxycycline for the indication of syphilis and other sexually transmitted infections, which is in the early stages of the clinical trial of phase I, from 2016.

In addition, the increase in government initiatives to raise awareness of STDs through campaigns and free diagnostic camps is also expected to propel the growth of the sexually transmitted disease treatment market during the forecast period. For example, the Centers for Disease Control and Prevention (CDC) in 2014 launched improving sexually transmitted disease programs through assessment, assurance, policy development and prevention. , or STD-AAPPS. Additionally, in 2018, Thunder Bay Group — HIV / AIDS / Hepatitis C Education and Support Provider, expanded access to hepatitis C medications for people with hepatitis C. level 2, after negotiating with the provinces and drug manufacturers.

However, low disease detection rate and late diagnosis of disease like HIV are the factors which are expected to hamper the growth of the sexually transmitted disease treatment market during the forecast period.

Sexually Transmitted Disease Treatment Market – Regional Analysis

On the basis of region, the sexually transmitted disease treatment market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. Among the regions, North America is expected to hold a dominant position in the market during the forecast period, owing to increasing government initiatives for disease awareness and implementation of prenatal screening programs.

In addition, Asia-Pacific is expected to be the fastest growing market in the treatment of sexually transmitted diseases, due to the high incidence of sexually transmitted infections due to unsafe sex practices in the region. For example, according to the Joint United Nations Program on HIV and AIDS (UNAIDS), Asia-Pacific had the second highest number of people living with HIV globally, at 5.1 million, in 2016. In addition, Asia-Pacific countries like China, India and Indonesia account for three quarters of the total people living with HIV.

Purchase this report with a flat rate US $ 2000 discount – https://www.coherentmarketinsights.com/promo/buynow/2005

Sexually Transmitted Disease (STD) Treatment Market – Competitive Landscape

The major players operating in the global prosthetic sleeves market are as follows: Merck & Co. Inc., Pfizer INC, GlaxoSmithKline Plc, Vertex Pharmaceuticals, Roche, Gilead Sciences Inc., AbbVie Inc., Johnson & Johnson and Bristol-Myers Squibb.

Key Highlights of the Sexually Transmitted Disease (STD) Treatment Market Report Table of Contents

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Global Sexually Transmitted Disease (STD) Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Impact on the Sexually Transmitted Disease (STD) Treatment Industry

Chapter 2 Global Sexually Transmitted Disease (STD) Treatment Competition by Types, Applications and Major Regions and Countries
2.1 Global Sexually Transmitted Disease (STD) Treatment (Volume & Value) by Type
2.3 Global Sexually Transmitted Disease (STD) Treatment (Volume & Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis

Chapter 4 Global Sexually Transmitted Disease (STD) Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 6 East Asia Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 7 Europe Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 8 South Asia Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 9 Southeast Asia Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 10 Middle East Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 11 Africa Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 12 Oceania Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 13 South America Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures of the Sexually Transmitted Disease (STD) Treatment Industry
Chapter 15 Global Sexually Transmitted Disease (STD) Treatment Market Forecast (2021-2027)
Chapter 16 Conclusion
Research methodology

About Coherent Market Insights

Coherent Market Insights is a leading market research and consulting firm providing action-ready syndicated research reports, personalized market analysis, advisory services and competitive analysis through various recommendations related to emerging market trends , technologies and potential opportunities in absolute dollars.

Contact us

Mr. Shah
Consistent market information
1001 4th avenue, # 3200
Seattle, Washington 98154
Phone: United States +12067016702 / United Kingdom +4402081334027
Email: [email protected]

Leave A Reply

Your email address will not be published.